Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,765 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
COGENT (COlorectal cancer GENeTics): an international consortium to study the role of polymorphic variation on the risk of colorectal cancer.
Tomlinson IP, Dunlop M, Campbell H, Zanke B, Gallinger S, Hudson T, Koessler T, Pharoah PD, Niittymäki I, Tuupanen S, Aaltonen LA, Hemminki K, Lindblom A, Försti A, Sieber O, Lipton L, van Wezel T, Morreau H, Wijnen JT, Devilee P, Matsuda K, Nakamura Y, Castellví-Bel S, Ruiz-Ponte C, Castells A, Carracedo A, Ho JW, Sham P, Hofstra RM, Vodicka P, Brenner H, Hampe J, Schafmayer C, Tepel J, Schreiber S, Völzke H, Lerch MM, Schmidt CA, Buch S, Moreno V, Villanueva CM, Peterlongo P, Radice P, Echeverry MM, Velez A, Carvajal-Carmona L, Scott R, Penegar S, Broderick P, Tenesa A, Houlston RS. Tomlinson IP, et al. Among authors: schreiber s. Br J Cancer. 2010 Jan 19;102(2):447-54. doi: 10.1038/sj.bjc.6605338. Epub 2009 Nov 17. Br J Cancer. 2010. PMID: 19920828 Free PMC article.
TLR-3 polymorphism is an independent prognostic marker for stage II colorectal cancer.
Castro FA, Försti A, Buch S, Kalthoff H, Krauss C, Bauer M, Egberts J, Schniewind B, Broering DC, Schreiber S, Schmitt M, Hampe J, Hemminki K, Schafmayer C. Castro FA, et al. Among authors: schreiber s. Eur J Cancer. 2011 May;47(8):1203-10. doi: 10.1016/j.ejca.2010.12.011. Epub 2011 Jan 14. Eur J Cancer. 2011. PMID: 21239167
Low penetrance susceptibility to glioma is caused by the TP53 variant rs78378222.
Enciso-Mora V, Hosking FJ, Di Stefano AL, Zelenika D, Shete S, Broderick P, Idbaih A, Delattre JY, Hoang-Xuan K, Marie Y, Labussière M, Alentorn A, Ciccarino P, Rossetto M, Armstrong G, Liu Y, Gousias K, Schramm J, Lau C, Hepworth SJ, Schoemaker M, Strauch K, Müller-Nurasyid M, Schreiber S, Franke A, Moebus S, Eisele L, Swerdlow A, Simon M, Bondy M, Lathrop M, Sanson M, Houlston RS. Enciso-Mora V, et al. Among authors: schreiber s. Br J Cancer. 2013 May 28;108(10):2178-85. doi: 10.1038/bjc.2013.155. Epub 2013 Apr 9. Br J Cancer. 2013. PMID: 23571737 Free PMC article.
Genetics and inflammatory bowel disease.
Schreiber S, Hampe J. Schreiber S, et al. Curr Opin Gastroenterol. 1999 Jul;15(4):315-21. doi: 10.1097/00001574-199907000-00007. Curr Opin Gastroenterol. 1999. PMID: 17023964
Study of Toll-like receptor gene loci in sarcoidosis.
Schürmann M, Kwiatkowski R, Albrecht M, Fischer A, Hampe J, Müller-Quernheim J, Schwinger E, Schreiber S. Schürmann M, et al. Among authors: schreiber s. Clin Exp Immunol. 2008 Jun;152(3):423-31. doi: 10.1111/j.1365-2249.2008.03621.x. Epub 2008 Apr 16. Clin Exp Immunol. 2008. PMID: 18422738 Free PMC article.
Genomics and inflammatory bowel disease.
Schreiber S, Hampe J. Schreiber S, et al. Curr Opin Gastroenterol. 2000 Jul;16(4):297-305. doi: 10.1097/00001574-200007000-00002. Curr Opin Gastroenterol. 2000. PMID: 17031092
2,765 results